9-2039776-ACAGCAGCAGCAGCAGCAGCAGCAGCAGCAG-ACAGCAGCAGCAGCAG

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2

The NM_003070.5(SMARCA2):​c.693_707delGCAGCAGCAGCAGCA​(p.Gln232_Gln236del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00351 in 150,530 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q231Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0035 ( 0 hom., cov: 26)
Exomes 𝑓: 0.0047 ( 12 hom. )
Failed GnomAD Quality Control

Consequence

SMARCA2
NM_003070.5 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.94

Publications

9 publications found
Variant links:
Genes affected
SMARCA2 (HGNC:11098): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is highly similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. Alternatively spliced transcript variants encoding different isoforms have been found for this gene, which contains a trinucleotide repeat (CAG) length polymorphism. [provided by RefSeq, Jan 2014]
SMARCA2 Gene-Disease associations (from GenCC):
  • intellectual disability-sparse hair-brachydactyly syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_003070.5
BP6
Variant 9-2039776-ACAGCAGCAGCAGCAG-A is Benign according to our data. Variant chr9-2039776-ACAGCAGCAGCAGCAG-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 212230.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00351 (528/150530) while in subpopulation NFE AF = 0.00491 (332/67584). AF 95% confidence interval is 0.00448. There are 0 homozygotes in GnomAd4. There are 231 alleles in the male GnomAd4 subpopulation. Median coverage is 26. This position passed quality control check.
BS2
High AC in GnomAd4 at 528 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCA2NM_003070.5 linkc.693_707delGCAGCAGCAGCAGCA p.Gln232_Gln236del disruptive_inframe_deletion Exon 4 of 34 ENST00000349721.8 NP_003061.3
SMARCA2NM_001289396.2 linkc.693_707delGCAGCAGCAGCAGCA p.Gln232_Gln236del disruptive_inframe_deletion Exon 4 of 34 NP_001276325.1
SMARCA2NM_139045.4 linkc.693_707delGCAGCAGCAGCAGCA p.Gln232_Gln236del disruptive_inframe_deletion Exon 4 of 33 NP_620614.2
SMARCA2NM_001289397.2 linkc.693_707delGCAGCAGCAGCAGCA p.Gln232_Gln236del disruptive_inframe_deletion Exon 4 of 33 NP_001276326.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCA2ENST00000349721.8 linkc.693_707delGCAGCAGCAGCAGCA p.Gln232_Gln236del disruptive_inframe_deletion Exon 4 of 34 5 NM_003070.5 ENSP00000265773.5

Frequencies

GnomAD3 genomes
AF:
0.00351
AC:
528
AN:
150430
Hom.:
0
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.000981
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00351
Gnomad ASJ
AF:
0.0104
Gnomad EAS
AF:
0.000981
Gnomad SAS
AF:
0.000212
Gnomad FIN
AF:
0.00482
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00491
Gnomad OTH
AF:
0.00532
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00468
AC:
6760
AN:
1445818
Hom.:
12
AF XY:
0.00452
AC XY:
3246
AN XY:
718570
show subpopulations
African (AFR)
AF:
0.00119
AC:
39
AN:
32786
American (AMR)
AF:
0.00302
AC:
129
AN:
42718
Ashkenazi Jewish (ASJ)
AF:
0.0116
AC:
300
AN:
25866
East Asian (EAS)
AF:
0.000130
AC:
5
AN:
38448
South Asian (SAS)
AF:
0.000212
AC:
18
AN:
84908
European-Finnish (FIN)
AF:
0.00559
AC:
289
AN:
51680
Middle Eastern (MID)
AF:
0.00287
AC:
16
AN:
5568
European-Non Finnish (NFE)
AF:
0.00517
AC:
5710
AN:
1104138
Other (OTH)
AF:
0.00425
AC:
254
AN:
59706
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
436
872
1308
1744
2180
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
216
432
648
864
1080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00351
AC:
528
AN:
150530
Hom.:
0
Cov.:
26
AF XY:
0.00314
AC XY:
231
AN XY:
73486
show subpopulations
African (AFR)
AF:
0.000978
AC:
40
AN:
40908
American (AMR)
AF:
0.00350
AC:
53
AN:
15128
Ashkenazi Jewish (ASJ)
AF:
0.0104
AC:
36
AN:
3462
East Asian (EAS)
AF:
0.000984
AC:
5
AN:
5082
South Asian (SAS)
AF:
0.000212
AC:
1
AN:
4712
European-Finnish (FIN)
AF:
0.00482
AC:
50
AN:
10366
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00491
AC:
332
AN:
67584
Other (OTH)
AF:
0.00526
AC:
11
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
24
49
73
98
122
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00329
Hom.:
12

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:6
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Oct 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Aug 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SMARCA2: BS1, BS2

Aug 29, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:2
Jul 24, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Benign:1
Oct 07, 2018
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.9
Mutation Taster
=182/18
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113070757; hg19: chr9-2039776; API